MoneyWorks4Me

Shilpa Medicare informs about disclosure

27 Oct 2022 Evaluate

Shilpa Medicare has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pivotal Enterprises & PACs.

The above information is a part of company’s filings submitted to BSE.


Shilpa Medicare Share Price

804.00 -17.90 (-2.18%)
17-Aug-2026 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.80
Dr. Reddys Labs. 1192.75
Cipla 1427.70
Lupin 2227.95
Zydus Lifesciences 1133.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: